Gene therapy Archives

News and Trends 7 Oct 2015

Nobel Prize in Chemistry 2015: DNA Repairing Mechanisms that Keep you Alive

DNA repair mechanisms are crucial to our existence. Without them, we would not survive because of DNA damage caused by the environment (e.g UV light damage, radiation etc.). This crucial research into discovery of three DNA repair mechanisms was led by Thomas Lindahl, Paul Modrich and Aziz Sancar who jointly received this years Nobel Prize […]

October 7, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 5 Oct 2015

€31M goes to a 15-month old Start-up tackling the leading cause of Dwarfism

TherAchon is a 15-month old start-up from the Nice area (France) which has attracted some serious US investors as of late, drawn by their pioneering protein therapy for Achondroplasia (the leading cause of Dwarfism). OrbiMed have now joined New Enterprise Associates and Versant Ventures in a €31 million series A pot for their pre-clinical candidate. […]

October 5, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Aug 2015

FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?

The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants to sell it in the US too, but the FDA makes it much more difficult than expected. UniQure’s financial report of the first half of 2015 shows good results, cash and cash equivalents of the company increased to €181.9M, compared with […]

August 28, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 22 Aug 2015

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Welcome in our Top of the week list! This week is full of uncommon stories. Did you know that we can create the best coffee from Biotech techniques? The New York-based startup Afineur can do this! Even more crazy, what do you think of a DNA-made computer? Quite strange, right! Well, if you’re curious, read […]

August 22, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 20 Aug 2015

DNA to play an essential role in the future of Computers?

You can do terrific things with DNA – convicting a murderer, confirming the right father … and building computers! As biomolecular computing is ever-growing, scientists from the University of East Anglia found a new way to convert DNA in a switching mechanism. This could be used in new bio-computers built from DNA. The structure of […]

August 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Top 5 Biotech Books to Enjoy your Summer on the Beach

Summer is a great time to read books and get inspired for the year to come. Here’s a Top 5 list of my recommendations to read before summer ends. 1. Genentech: The Beginnings of Biotech Genentech is considered the founder of the Biotech industry in the late 80s. It started from breakthrough science, crazy scientists and very risk-taking […]

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 12 Aug 2015

A Tale of Love for UniQure and Bristol-Myers Squibb

In May, Bristol-Myers Squibb (BMS) nailed down the exclusive access to uniQure’s gene therapy platform to treat cardiovascular diseases. Everything seems to work out fine as BMS paid $53M (€47M) for three new targets and additional shares to own nearly 10% of the company. UniQure is a Dutch pioneer in the field of gene therapy. It […]

August 12, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 20 Jul 2015

Theravectys’ HIV Cure on the Road to Success

Theravectys just announced positive results of its HIV drug candidate in a phase I/II study. The therapeutic vaccine using lentivirus could be the first cure available for the 35 million people currently suffering from this worldwide epidemic. Paris-based Theravectys presented detailed results from its phase I/II study at the 2015 Towards an HIV Cure Symposium in Vancouver, Canada. The trial currently enrolled 38 HIV-positive patients […]

July 20, 2015 - 3 minutesmins - By Joachim Eeckhout

eye Bayer Healthcare Johns Hopkins University

News and Trends 9 Jul 2015

Vision specialist Gensight eyes a €90M IPO on NASDAQ

French Gensight intends to raise one of the biggest European IPOs on the American stock market. The gene-therapy specialist will pursue €90.6M to advance with two early-stage candidates for orphan eyes diseases. Gensight will travel across the Ocean to look for the same success its compatriots had on the American stock market. The company will […]

July 9, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 8 Jul 2015

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

Good news for patients suffering from cystic fibrosis! Imperial Innovations‘ patented gene therapy could improve the patients’ breathing provoking any side effects. An innovation that could help fulfill this unmet medical need. Cystic fibrosis is the most common deadly genetic disease in Europe. Gene deficiency leads to thickening mucus that obstructs lungs and results in […]

July 8, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Jun 2015

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its US presence and benefit from Boston’s leading position in the gene therapy field. Gene Therapy is the next big thing in Biotech and is now moving from a theoretical dream to reality. Boston is clearly the hotspot for […]

June 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 1 Jun 2015

DNA Therapeutics presents positive results for its breakthrough Advanced Cancer Therapy

ASCO Annual Meeting keeps bringing positive results of European companies that cross the ocean to present their clinical trial outcomes. DNA Therapeutics, the French biopharma, presented the results of the first-in-man phase I/IIa trial of DT01 in patients with cutaneous metastatic melanoma. Cancer cells can easily repair themselves after damage incurred in their DNA from […]

June 1, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Gene therapy

Nobel Prize in Chemistry 2015: DNA Repairing Mechanisms that Keep you Alive

€31M goes to a 15-month old Start-up tackling the leading cause of Dwarfism

FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

DNA to play an essential role in the future of Computers?

Top 5 Biotech Books to Enjoy your Summer on the Beach

A Tale of Love for UniQure and Bristol-Myers Squibb

Theravectys’ HIV Cure on the Road to Success

Vision specialist Gensight eyes a €90M IPO on NASDAQ

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

DNA Therapeutics presents positive results for its breakthrough Advanced Cancer Therapy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!